🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05921682
Recruiting Observational

Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

NCT05921682 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Started
2023-05-28
Last updated
2024-09-20

Condition(s) studied

Heat Stroke

Investigational drug(s) / intervention(s)

observation

observation: This study is an observational study. Patients will receive conventional cooling measures and organ function support.

Study summary

The goal of this observational study is to explore the optimal target body temperature in first 24 hours and the relationship between body temperature and adverse outcomes of heat stroke.

The main questions it aims to answer are:

* the optimal target body temperature at 0.5 h, 2 h, and the lowest body temperature of heat stroke.
* the best body temperature at the cutting point of stop cooling.
* The relationship between the volume and speed of ice saline infusion and the cooling effect.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * ≥ 18 years; ② diagnosed as heat stroke; ③ Informed consent from patients or family members. Exclusion Criteria: * need immediate cardiopulmonary resuscitation; ② transferred from another hospital; ③ with severe underlying organ insufficiency; ④ pregnant women.

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Yiwu Central Hospital Yiwu Zhejiang Recruiting
Dongyang People's Hospital Dongyang China Recruiting
The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou China Recruiting
Jinhua Municipal Central Hospital Jinhua China Recruiting
Jinhua People's Hospital Jinhua China Recruiting
Lanxi People's Hospital Lanxi China Recruiting

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05921682 on ClinicalTrials.gov ↗ ← All trials in China